Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2025-12-24 @ 9:54 PM
NCT ID:
NCT05627232
Brief Title:
Tazemetostat and Palbociclib With CPX-351for R/R AML
Official Title:
A Two-Part Phase 1b Study Evaluating the Combination of Tazemetostat and CPX-351 (Part 1) and Tazemetostat and CPX-351 Following Pre-Treatment With Palbociclib (Part 2) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Study:
NCT05627232
Protocol Section:
NCT05627232